Cancer survivorship care during COVID-19-perspectives and recommendations from the MASCC survivorship study group
- PMID: 32451702
- PMCID: PMC7247777
- DOI: 10.1007/s00520-020-05544-4
Cancer survivorship care during COVID-19-perspectives and recommendations from the MASCC survivorship study group
Conflict of interest statement
The authors declare that they have no conflicts of interest.
References
-
- CDC. Coronavirus Disease 2019 (COVID-19) 2020 [Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/preventio... CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Fprevention.html
-
- Schilsky R. Common questions about COVID-19 and cancer: answers for patients and survivors: Am Soc Clin Oncol; 2020 [Available from: https://www.cancer.net/blog/2020-05/common-questions-about-covid-19-and-...
-
- van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, et al. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14):2188–2194. doi: 10.1016/j.ejca.2011.04.034. - DOI - PubMed
-
- Girgis A, Durcinoska I, Koh ES, Ng W, Arnold A, Delaney GP, PROMPT-Care Pathways Working Group Development of health pathways to standardize cancer care pathways informed by patient-reported outcomes and clinical practice guidelines. JCO Clin Cancer Inform. 2018;2:1–13. doi: 10.1200/CCI.18.00024. - DOI - PubMed
